Stocks · Healthcare · Medical - Healthcare Plans

Cigna Corporation CI

$270.53 +0.96% Close, Oct 2, 2026 · NYSE · Market cap $71.48B

Inexpensive vs sectorLow risk

Next earnings report: Oct 29, 2026

Scroll or pinch to zoom, drag to move. Daily prices adjusted for splits. Markers: E = earnings (green beat, red miss), S = split, D = dividend.

Three things to know

  1. Earnings beat analyst estimates in each of the last 6 quarters (average surprise over the last four: +2.5%).
  2. The shares trade at 11.2× trailing earnings, lower than 86% of the company's own readings over the past five years.
  3. The stock is in a downtrend: below its 200-day average, with the 50-day average below the 200-day.

PromtFinance scores

Each score is a percentile within the Healthcare sector (0–100). Under each score: how the stock ranks in its sector on every component. As of Oct 5, 2026.

Growth70Positive

How fast revenue, earnings and cash flow are growing.

  • Revenue growth (TTM, YoY)Bottom 47%
  • EPS growth (TTM, YoY)Top 33%
  • FCF growth (TTM, YoY)Top 13%
  • Revenue growth, 3-year CAGRTop 40%
  • Revenue growth accelerationBottom 40%
Quality56Neutral

Returns on capital, margins, earnings quality and balance-sheet strength.

  • Return on invested capitalTop 19%
  • Gross marginBottom 10%
  • Operating marginTop 37%
  • Cash conversion (OCF / net income)Top 49%
  • Accruals (lower is better)Bottom 27%
  • Net debt / EBITDA (lower is better)Bottom 37%
  • Interest coverTop 20%
Value99Exceptional

How cheap the shares are relative to earnings, cash flow and their own history.

  • Earnings yieldTop 4%
  • Free-cash-flow yieldTop 5%
  • EBITDA / enterprise valueTop 6%
  • Sales / enterprise valueTop 2%
  • P/E vs own 5-year history (lower is better)Top 28%
Momentum39Weak

Strength and persistence of the price trend, including versus the S&P 500.

  • 12-month return excluding last monthBottom 33%
  • 6-month returnBottom 44%
  • 1-year return vs S&P 500Bottom 38%
  • Distance from 52-week highTop 22%
  • Trend checklist (0–4)Bottom 14%
Revisions58Neutral

Earnings surprises and analyst sentiment (estimate-revision history is being collected).

  • Average EPS surprise, last 4 quartersBottom 48%
  • Consecutive EPS beatsTop 12%
  • Share of analysts rating BuyBottom 45%
  • Upside to consensus price targetBottom 32%
Stability94Exceptional

Low volatility, shallow drawdowns, low market sensitivity and modest leverage.

  • Volatility, 60 days (lower is better)Top 7%
  • Maximum drawdown, 3 yearsTop 7%
  • Beta vs S&P 500 (lower is better)Top 6%
  • Net debt / EBITDA (lower is better)Bottom 37%

What changed

Latest four quarters versus the same period a year earlier (growth: versus one quarter earlier).

MeasureBeforeNow
Revenue growth (YoY)8.8%7.7%↓
EPS growth (YoY)30.6%31.9%↑
Gross margin10.5%11.7%↑
Operating margin3.5%3.5%↓
FCF margin1.5%3.2%↑

Fundamental momentum

MeasureNow (TTM)Year / quarter beforeSector rank
Revenue growth (TTM, YoY)7.7%8.8%↓Bottom 47%
EPS growth (TTM, YoY)31.9%30.6%↑Top 33%
Gross margin11.7%10.5%↑Bottom 10%
Operating margin3.5%3.5%↓Top 37%
Net margin2.3%1.9%↑—
Free-cash-flow margin3.2%1.5%↑—
Return on invested capital7.7%—Top 19%
Revenue growth, 3-year CAGR15.1%—Top 40%

Quality of earnings and balance sheet

Cash conversion (OCF / net income)Above 1× means profits are backed by cash.
1.60×
Accruals (net income − OCF) / assetsLower is better; high accruals can signal weaker earnings quality.
-2.5%
Stock-based compensation / revenueA cost to shareholders through dilution.
0.0%
Receivables growth vs revenue growthReceivables growing much faster than sales can be a warning.
-8.9 pp
Net debt / EBITDABelow 1× is conservative; above 3× is high leverage.
2.17×
Interest cover (operating income / interest)How many times operating profit covers interest.
7.0×

Shareholder returns

Dividend yield (dividends paid, TTM)
2.27%
Net buyback yield (TTM)
1.48%
Shareholder yield
3.76%
Share count change, 1 year
-1.6%
Share count change, 3-year CAGR
-3.8%

Shareholder yield = dividends + net buybacks over the last four quarters, divided by market cap.

Based on the four quarters through Jun 30, 2026 (filed Jul 30, 2026).

Earnings and expectations

Earnings momentum

Consecutive EPS beats
6
Beats in the last 8 reports
7 of 8
Average EPS surprise, last 4
+2.5%
Average 2-day reaction, last 8
-4.1%
Positive 20 days after report
3 of 8

Analysts

Consensus price target
$342.08
Target vs current price
+26.4%
Analysts with a rating
39
Share rating Buy or Strong Buy
74%
Consensus rating
Buy

How the stock reacted to recent reports

Report dateEPS surprise2 days5 days20 days60 days
Jul 30, 2026+2.4%-3.0%-8.8%-5.3%—
Apr 30, 2026+2.5%-0.6%-3.5%-2.7%-0.4%
Feb 5, 2026+2.5%+4.7%+8.5%+3.5%+4.1%
Oct 30, 2025+2.5%-17.4%-13.2%-6.9%-9.7%
Jul 31, 2025+0.6%-10.2%-9.4%+0.7%+2.4%
May 2, 2025+6.1%-0.1%-0.6%-5.5%-12.8%
Jan 30, 2025-15.3%-6.7%-3.3%-0.1%+10.6%
Oct 31, 2024+3.9%+0.6%+0.7%+7.5%-3.1%

Returns from the close before each report. Past reactions do not determine future ones.

Earnings history

Report dateEPSEstimateSurpriseRevenue
Jul 30, 2026$7.78$7.60+2.4%$71.67B
Apr 30, 2026$7.79$7.60+2.5%$68.49B
Feb 5, 2026$8.08$7.88+2.5%$72.47B
Oct 30, 2025$7.83$7.64+2.5%$69.75B
Jul 31, 2025$7.20$7.16+0.6%$67.23B
May 2, 2025$6.74$6.35+6.1%$65.50B
Jan 30, 2025$6.64$7.84-15.3%$65.72B
Oct 31, 2024$7.51$7.23+3.9%$62.77B

Valuation in context

MultipleNow5-year median5-year percentileSector rank (cheapness)
P/E (trailing)11.2×14.6×14thTop 4%
P/E (forward)8.9×———
EV / EBITDA8.2×——Top 6%
EV / Sales0.34×——Top 2%
Free-cash-flow yield12.75%——Top 5%
Earnings yield8.93%——Top 4%

P/E over the past five years

Range 9.0× – 29.7× since Jun 30, 2021. Each point: price on the filing date divided by trailing-twelve-month EPS known then.

What moved the stock over the past year

Price return, 1 year
-7.2%
Earnings per share growth (TTM)
+31.9%
Change in P/E multiple
-18.4%

Most of the move came from earnings growth.

Technical state

Trend checklist

  • ✗ Price above 20-day average
  • ✗ Price above 50-day average
  • ✗ Price above 200-day average
  • ✗ 50-day average above 200-day
  • ✗ MACD histogram positive

Trend quality

Days above the 50-day average
0
Days above the 200-day average
0
50-day average slope (20 days)
-1.6%
200-day average slope (20 days)
+0.2%
Distance from 50-day average
-3.0%
Distance from 200-day average
-3.4%
RSI (14)
44.1
Relative volume
1.16×

Risk and drawdowns

Volatility, 60 days (annualized)
28.1%
Volatility vs own 5-year history
63th percentile · Normal for this stock
Beta vs S&P 500 (2 years, weekly)
0.23
Correlation with S&P 500
0.12
Current drawdown from 1-year high
-13.0%
Maximum drawdown, 3 years
-33.4%

Largest declines in the past six years

From peakTo lowDeclineLengthRecovery
Sep 16, 2024Oct 31, 2025-33.4%283 daysNot yet recovered
Dec 12, 2022May 30, 2023-28.5%115 days181 days (Feb 16, 2024)
May 10, 2021Nov 30, 2021-28.1%142 days97 days (Apr 20, 2022)
Apr 1, 2024Jul 5, 2024-12.3%66 days41 days (Sep 3, 2024)
Nov 11, 2020Dec 22, 2020-11.8%28 days13 days (Jan 12, 2021)

Declines of 10% or more from a closing high, measured on daily closes.

Financial statements

Market cap
$71.48B
P/E (TTM)
11.2
EPS, diluted (TTM)
$24.16
Revenue (TTM)
$282.38B
Dividend yield
2.29%
52-week range
$239.51 – $315.47
FY 2021FY 2022FY 2023FY 2024FY 2025
Revenue$174.07B$180.52B$195.26B$247.12B$274.95B
Gross profit$22.95B$23.50B$25.18B$25.96B$25.99B
Operating income$7.94B$8.45B$8.54B$9.42B$9.13B
Net income$5.37B$6.70B$5.16B$3.43B$5.96B
EPS (diluted)$15.75$21.41$17.39$12.12$22.17
Q3 2024Q4 2024Q1 2025Q2 2025Q3 2025Q4 2025Q1 2026Q2 2026
Revenue$63.69B$65.65B$65.50B$67.23B$69.75B$72.47B$68.49B$71.67B
Net income$739.0M$1.42B$1.32B$1.53B$1.87B$1.23B$1.65B$1.66B
EPS (diluted)$2.63$5.13$4.85$5.71$6.97$4.64$6.26$6.29
FY 2021FY 2022FY 2023FY 2024FY 2025
Operating cash flow$7.19B$8.66B$11.81B$10.36B$9.60B
Capital expenditure-$1.15B-$1.29B-$1.57B-$1.41B-$1.21B
Free cash flow$6.04B$7.36B$10.24B$8.96B$8.39B
Dividends paid-$1.34B-$1.38B-$1.45B-$1.57B-$1.61B
Net share buybacks-$7.42B-$7.22B-$2.10B-$6.73B-$3.42B

Cash outflows are shown as negative numbers.

Cash and short-term investments
$6.30B
Total assets
$157.08B
Total liabilities
$114.17B
Total debt
$31.88B
Net debt
$25.58B
Shareholders’ equity
$42.62B

As of Jun 30, 2026 (filed Jul 30, 2026).

Dividends

Ex-dateAmountPaid
Sep 8, 2026$1.56Sep 23, 2026
Jun 4, 2026$1.56Jun 18, 2026
Mar 5, 2026$1.56Mar 19, 2026
Dec 4, 2025$1.51Dec 18, 2025
Sep 4, 2025$1.51Sep 18, 2025
Jun 3, 2025$1.51Jun 18, 2025
Mar 5, 2025$1.51Mar 20, 2025
Dec 4, 2024$1.40Dec 19, 2024

Short interest

Shares sold short
6,562,998
Days to cover
4.60
Change vs previous report
+4.6%

FINRA short interest, settlement date Sep 15, 2026.

Stock splits

Jun 5, 2007
3-for-1
May 18, 1998
3-for-1